The Journal Therapeutics (JPET) Cannabidiol Enhances Intestinal CB2 Receptor Expression and Activation Increasing Regulatory T Cells and Reduces Murine Acute Graft-Versus-Host Disease without Interfering with The Graft-Versus-Leukemia Response

1Departamento de Farmacologia-ICB/UFMG; 2Programa de Pós-graduação em Fisiologia e Farmacologia da UFMG; 3-Departamento de Enfermagem Básica da Escola de Enfermagem da UFMG; 4Departamento de Patologia Geral do Instituto de Ciências Biológicas da UFMG. 5 -Departamento de Morfologia CPDFICB/UFMG; 6-Departamento de Bioquímica e Imunologia, CPDF-ICB/UFMG. This article has not been copyedited and formatted. The final version may differ from this version. JPET Fast Forward. Published on March 3, 2021 as DOI: 10.1124/jpet.120.000479

[1]  R. Or,et al.  Cannabinoids Reduce Inflammation but Inhibit Lymphocyte Recovery in Murine Models of Bone Marrow Transplantation , 2019, International journal of molecular sciences.

[2]  N. Beyersdorf,et al.  During acute graft versus host disease CD28 deletion in donor CD8+, but not CD4+, T cells maintain antileukemia responses in mice , 2018, European journal of immunology.

[3]  E. L. Potter,et al.  Delineating tissue-specific alloimmunity during acute GVHD , 2018, The Journal of Immunology.

[4]  John W. Adams,et al.  APD371: a potent, highly selective, full agonist of the human CB 2 receptor with sustained analgesic effects in rodents , 2018 .

[5]  A. Wensing,et al.  Viral reactivations and associated outcomes in the context of immune reconstitution after pediatric hematopoietic cell transplantation , 2017, The Journal of allergy and clinical immunology.

[6]  Zimin Sun,et al.  European Group for Blood and Marrow Transplantation Risk Score Predicts the Outcome of Patients with Acute Leukemia Receiving Single Umbilical Cord Blood Transplantation. , 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[7]  J. Serody,et al.  Altered homeostatic regulation of innate and adaptive immunity in lower gastrointestinal tract GVHD pathogenesis , 2017, The Journal of clinical investigation.

[8]  He Huang,et al.  Risk Factors for Graft-Versus-Host Disease After Transplantation of Hematopoietic Stem Cells from Unrelated Donors in the China Marrow Donor Program , 2017, Annals of transplantation.

[9]  M. Petri,et al.  Long-term systemic lupus erythematosus disease control after allogeneic bone marrow transplantation , 2017, Lupus.

[10]  M. Teixeira,et al.  Alemtuzumab as graft-versus-host disease (GVHD) prophylaxis strategy in a developing country: lower rate of acute GVHD, increased risk of cytomegalovirus reactivation , 2017, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[11]  R. Jenq,et al.  Role of the intestinal mucosa in acute gastrointestinal GVHD. , 2016, Blood.

[12]  S. Katz,et al.  Therapeutic Use of Cannabis in Inflammatory Bowel Disease. , 2016, Gastroenterology & hepatology.

[13]  Marcos González,et al.  The Genotype of the Donor for the (GT)n Polymorphism in the Promoter/Enhancer of FOXP3 Is Associated with the Development of Severe Acute GVHD but Does Not Affect the GVL Effect after Myeloablative HLA-Identical Allogeneic Stem Cell Transplantation , 2015, PloS one.

[14]  B. A. David,et al.  Cannabidiol Rescues Acute Hepatic Toxicity and Seizure Induced by Cocaine , 2015, Mediators of inflammation.

[15]  S. Mineishi,et al.  State-of-the-art acute and chronic GVHD treatment , 2015, International Journal of Hematology.

[16]  A. Teixeira,et al.  Cannabidiol increases survival and promotes rescue of cognitive function in a murine model of cerebral malaria , 2015, Neuroscience.

[17]  C. Uherek,et al.  A specific CD4 epitope bound by tregalizumab mediates activation of regulatory T cells by a unique signaling pathway , 2014, Immunology and cell biology.

[18]  C. N. Huu,et al.  Differences in receptor binding affinity of several phytocannabinoids do not explain their effects on neural cell cultures. , 2014, Neurotoxicology and teratology.

[19]  R. Negrin,et al.  Regulatory T cells and natural killer T cells for modulation of GVHD following allogeneic hematopoietic cell transplantation. , 2013, Blood.

[20]  W. Drobyski,et al.  The Role of Regulatory T Cells in the Biology of Graft Versus Host Disease , 2013, Front. Immunol..

[21]  M. Storr,et al.  A potential role for GPR55 in gastrointestinal functions , 2012, Current opinion in pharmacology.

[22]  W. Murphy,et al.  Advances in graft-versus-host disease biology and therapy , 2012, Nature Reviews Immunology.

[23]  M. Glass,et al.  A new cannabinoid CB2 receptor agonist HU‐910 attenuates oxidative stress, inflammation and cell death associated with hepatic ischaemia/reperfusion injury , 2012, British journal of pharmacology.

[24]  R. Cuomo,et al.  Cannabidiol Reduces Intestinal Inflammation through the Control of Neuroimmune Axis , 2011, PloS one.

[25]  Z. Vogel,et al.  Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis‐like disease in C57BL/6 mice , 2011, British journal of pharmacology.

[26]  J. Dipersio,et al.  Mouse models of graft-versus-host disease: advances and limitations , 2011, Disease Models & Mechanisms.

[27]  M. Peppa,et al.  Hypertension and other morbidities with Cushing’s syndrome associated with corticosteroids: a review , 2011, Integrated blood pressure control.

[28]  D. Poetker,et al.  A comprehensive review of the adverse effects of systemic corticosteroids. , 2010, Otolaryngologic clinics of North America.

[29]  M. Teixeira,et al.  The CCL3/Macrophage Inflammatory Protein-1α–Binding Protein Evasin-1 Protects from Graft-versus-Host Disease but Does Not Modify Graft-versus-Leukemia in Mice , 2010, The Journal of Immunology.

[30]  R. Capasso,et al.  Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis , 2009, Journal of Molecular Medicine.

[31]  H. Kolb.  Graft-versus-leukemia effects of transplantation and donor lymphocytes. , 2008, Blood.

[32]  M. Barton-Burke,et al.  Graft-versus-host disease: a complex long-term side effect of hematopoietic stem cell transplant. , 2008, Oncology.

[33]  J. Wijdenes,et al.  CD4‐mediated functional activation of human CD4+CD25+ regulatory T cells , 2007, European journal of immunology.

[34]  W. Shlomchik.  Graft-versus-host disease , 2007, Nature Reviews Immunology.

[35]  Mark Ende,et al.  Hematopoietic stem-cell transplantation. , 2006, The New England journal of medicine.

[36]  R. Pertwee.  The pharmacology of cannabinoid receptors and their ligands: an overview , 2006, International Journal of Obesity.

[37]  J. Vose,et al.  Graft-versus-host disease: how to translate new insights into new therapeutic strategies. , 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[38]  J. Serody,et al.  In vivo imaging of graft-versus-host-disease in mice. , 2004, Blood.

[39]  C. Fathman,et al.  CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation , 2003, Nature Medicine.

[40]  R. Soiffer,et al.  The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation. , 2001, Blood.

[41]  D. Blaise,et al.  Peripheral Blood Stem Cell and Bone Marrow Transplantation for Solid Tumors and Lymphomas: Hematologic Recovery and Costs: A Randomized, Controlled Trial , 1997, Annals of Internal Medicine.

[42]  R. Hoover,et al.  Solid cancers after bone marrow transplantation. , 1997, The New England journal of medicine.

[43]  E. Milford,et al.  IMPACT OF RACIAL GENETIC POLYMORPHISM ON THE PROBABILITY OF FINDING AN HLA‐MATCHED DONOR , 1995, Transplantation.

[44]  N. Schmitz,et al.  Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe , 2002, Bone Marrow Transplantation.

[45]  A. Marmont,et al.  Immune ablation followed by allogeneic or autologous bone marrow transplantation: A new treatment for severe autoimmune diseases? , 1994, Stem cells.

[46]  E. D. Tomas.  [Bone marrow transplantation in leukemia]. , 1983, Terapevticheskii arkhiv.